Company profile
Proteome Sciences
Leading Protein Biomarker Discovery and Validation for Precision Medicine Across Healthcare
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUyMzA3NDIzN2FkaXF6a2N4 | Paper/PDF filed
Published 27 May 2026 22:59
Last accounts made up date
Last confirmation statement made up date
CH01 | Transaction MzQ0MTc2MTI4MmFkaXF6a2N4
Published 04 Nov 2024 11:29
CH01 | Transaction MzQ0MTc2MTI5NWFkaXF6a2N4
Published 04 Nov 2024 11:23
CS01 | Transaction MzQ0MTg5MzM3N2FkaXF6a2N4
Published 04 Nov 2024 01:12
Company registered at Companies House
http://www.proteomics.com/
Joint patents with King's College London relating to tau phosphorylation in Alzheimer's disease. Development of TMT methodology for quantitative proteomics. Biomarker assays
